Your trusted destination for CME, CPD & Medical Education across the Middle East.
The Sharkia Endocrinology & Diabetes Association (SHEDA) World Diabetes Day Conference centers on the theme "Early Action On Diabetes" and gathers endocrinologists, diabetologists, internists, cardiologists, primary care physicians, and clinical nutritionists to highlight early screening, targeted intervention, advanced pharmacotherapy, and comprehensive cardio-renal-metabolic risk management.
The Sharkia Endocrinology & Diabetes Association (SHEDA) World Diabetes Day Conference stands as a landmark regional medical congress dedicated to advancing preventive diabetes care, early clinical intervention, and multi-specialty metabolic health management. Hosted by the Sharkia Endocrinology & Diabetes Association (SHEDA) in scientific partnership with Pure Spot Events Management, this two-day scientific event takes place from November 12 to November 13, 2026, at the Grand Hotel in Port Said, Egypt. Organized to align with international World Diabetes Day initiatives, the conference centers around the vital theme, "Early Action On Diabetes," assembling academic leaders, university faculty, consultant endocrinologists, diabetologists, internal medicine specialists, cardiologists, nephrologists, and clinical nutritionists from across Egypt. The extensive scientific curriculum offers an immersive, multi-disciplinary educational program delivered through plenary lectures, clinical case panels, interactive symposia, and practical workshops. The primary clinical focus centers on transforming traditional reactive management into proactive, early-stage therapeutic interventions. Key thematic modules address early diagnostic biomarkers, prediabetes risk stratification, population-wide screening strategies, and personalized medical nutrition therapy. Delegates will examine the latest evidence-based treatment algorithms utilizing organ-protective disease-modifying agents—including SGLT2 inhibitors, GLP-1 receptor agonists, dual incretin therapies, and ultra-long-acting insulin regimens—with a dedicated focus on weight management and glycemic variability. Beyond blood glucose regulation, the conference program emphasizes comprehensive cardio-renal-metabolic risk reduction and the early prevention of chronic diabetes complications. Experts will share clinical insights on managing diabetic kidney disease, cardiovascular comorbidities, peripheral artery disease, diabetic neuropathy, and retinopathy. Sessions also explore modern diabetes management technologies, such as continuous glucose monitoring (CGM) interpretation, digital health platforms, and patient self-management education. By promoting active scientific dialogue and updating standard-of-care guidelines, the SHEDA World Diabetes Day Conference equips healthcare providers with actionable tools to detect diabetes earlier, optimize long-term clinical outcomes, and enhance the quality of life for patients across the region.
Identifying high-risk patients before clinical onset using advanced biomarkers.
Reviewing current guidelines for population-based and targeted diabetes screening.
The role of diet, exercise, and weight management in early diabetes intervention.
Evaluating first-line therapies and early combination treatments for newly diagnosed patients.
Addressing early signs of cardiovascular disease in diabetic and prediabetic patients.
Strategies to prevent early neuropathy, nephropathy, and retinopathy.
Techniques to ensure patient compliance with early treatment regimens and lifestyle changes.
Addressing the mental health impact of a new diabetes diagnosis and fostering resilience.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow